Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483860 · ClinicalTrials.gov registry record · Phase 1
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT00483860 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 59 participants.
The verdict
NCT00483860, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
To determine the effect of renal impairment and prior platinum-based chemotherapy on the safety and blood levels of topotecan administered orally
Interventions
- DRUG Topotecan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2007-06-20 |
| Est. Completion | 2012-02-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483860
The ClinicalTrials.gov registry entry for NCT00483860 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topotecan is the first listed.
NCT00483860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00483860 about?
NCT00483860 is a clinical study titled "A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function". To determine the effect of renal impairment and prior platinum-based chemotherapy on the safety and blood levels of topotecan administered orally
What is the current status of trial NCT00483860?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2007-06-20. Estimated completion is 2012-02-06.
What interventions are being tested in trial NCT00483860?
The interventions under investigation include: Topotecan (DRUG).
Who is sponsoring clinical trial NCT00483860?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.